3+ day, 1+ hour ago  (465+ words) Parse Biosciences and bit. bio have announced an alliance to create a comprehensive map of transcription factor-driven cell identity, combining single cell sequencing with large-scale causal transcriptomics. Parse Biosciences and bit. bio have announced a new alliance aimed at creating…...

4+ day, 20+ hour ago  (537+ words) An international research team has deployed a two-stage machine learning system to overcome data limitations in targeting glycoprotein 130, achieving 56 percent tumour growth inhibition in xenograft models with structurally optimised indolopyridine derivatives. The international study, led by Professor Wenying Yu and…...

3+ week, 4+ day ago  (581+ words) A new University of South Florida study examines how AI models predict immune system responses to antigens, offering a framework to evaluate computational tools used in immunotherapy and vaccine development. Artificial intelligence is now a huge tool for scientists in…...

1+ mon, 1+ day ago  (348+ words) Biotechnology company AAX Biotech has announced a new partnership with evitria AG to strengthen their early-stage antibody development. AAX Biotech, known for developing technologies for antibody-based therapies, will collaborate with evitria, a specialist provider of antibody engineering and expression services,…...

1+ mon, 3+ day ago  (606+ words) An automated imaging system developed at ETH Zurich uses AI to detect pain in laboratory mice through facial expression analysis, offering standardised assessment that reduces observer bias and animal stress." A white plastic box with an"orange floor may not…...

1+ mon, 1+ week ago  (361+ words) 10x Genomics has announced the launch of Atera, a new in situ spatial biology platform designed to deliver whole-transcriptome spatial analysis with single-cell sensitivity at unprecedented scale. The company said the platform has been engineered to enable researchers to study gene…...

1+ mon, 3+ week ago  (146+ words) The role of artificial intelligence (AI) in drug design has fundamentally shifted from a speculative tool to a central pillar of pharmaceutical research and development (R&D). Sino Biological plays a critical role in this evolving landscape by acting as an…...

2+ mon, 6+ day ago  (856+ words) Designing gene control from scratch is becoming possible. Syn Gen Sys is using computational design to create synthetic promoters for advanced therapies. This work is led in part by Professor David James, co-founder of Syn Gen Sys and professor of…...

2+ mon, 1+ week ago  (1273+ words) Proteins are often studied as static structures, yet they behave dynamically in living systems. Tiffanwy Klippel-Cooper of Omnigeni Q explains how physics-based modelling could help researchers better understand drug targets. A new approach emerging from Australian start-up Omnigeni Q aims…...

2+ mon, 1+ week ago  (314+ words) Lab Genius Therapeutics will present preclinical data for LGTX-101, its AI-designed Nectin-4 x CD3 T-cell engager, at AACR 2026 in San Diego. Lab Genius Therapeutics, a drug discovery company that combines artificial intelligence (AI), high-throughput experimentation and machine learning to develop next-generation…...